S-1/A: iCoreConnect Amends Offering, Increases Size to $8.25 Million

iCoreConnect Inc. amends its February 2024 offering, increasing the offering size to $8.25 million and modifying amortization payment terms.

Summary

• ICoreConnect Inc. has amended its February 2024 securities purchase agreements, increasing the offering size from $3.3 million to $8.25 million.
• The amendment allows the company to accelerate amortization payments on both existing and future notes issued under the February 2024 offering.
• Holders of the First Closing Notes can voluntarily convert amounts under the notes at a conversion price equal to the Market Price, at the company's option.
• Future Notes will also have a voluntary conversion option at the Market Price, and First Closing Note Optional Conversions will not adjust the conversion price of Future Notes.
• The company is required to file a preliminary information statement on Schedule 14A with the SEC regarding Shareholder Approval by April 30, 2024.
• The initial Registration Statement must include no less than 6,600,000 shares of Common Stock.
• The company represents that it has the authority to enter into the amendment and that the amendment is a binding obligation.
• Holders represent that they are accredited investors.
• The company must secure the listing of additional Common Stock issued under the amended February 2024 Offering.
• The company is required to file a Current Report on Form 8-K describing the terms of the transactions contemplated by the amendment by a specified deadline.
• The company acknowledges that any confidentiality obligations with the Holders terminate upon the filing of the 8-K Filing.
• The company and the Holders are restricted from issuing press releases or public statements without prior approval, except in conformity with the 8-K Filing or as required by law.
• The amendment is intended for the benefit of the parties and is not enforceable by any third party.
• The obligations of the Holders are several and not joint.
• The amendment can only be waived, modified, supplemented, or amended in a written instrument signed by the company and the Holders.
• The amendment is binding upon successors and assigns.
• Each party is responsible for their own fees and expenses.
• The amendment takes precedence over conflicting provisions in the Transaction Documents.
• The amendment may be executed in counterparts.

Sentiment

Score: 7

Explanation: The document is a legal agreement outlining changes to a financial offering. The sentiment is neutral, reflecting the professional and objective nature of the content. The increase in offering size is a positive development, but the document also includes restrictions and obligations.

Positives

• The increased offering size provides iCoreConnect with additional capital.
• The ability to accelerate amortization payments offers the company greater financial flexibility.
• Voluntary conversion options may attract investors and potentially reduce debt.
• The company has the requisite corporate power and authority to enter into and consummate the transactions contemplated by this Amendment.

Negatives

• The company is required to file a preliminary information statement on Schedule 14A with the SEC regarding Shareholder Approval by April 30, 2024, which may require additional resources.
• The company is required to file a Current Report on Form 8-K describing the terms of the transactions contemplated by the amendment by a specified deadline, which may require additional resources.
• The company and the Holders are restricted from issuing press releases or public statements without prior approval, except in conformity with the 8-K Filing or as required by law, which may limit communication flexibility.

Risks

• Failure to meet the filing deadlines for the preliminary information statement or the 8-K Filing could result in penalties or non-compliance.
• The voluntary conversion options may not be exercised by holders, leaving the company with the debt burden.
• The company's ability to accelerate amortization payments may be limited by its financial condition.
• The company may be unable to secure the listing of additional Common Stock issued under the amended February 2024 Offering.

Future Outlook

The company intends to file a preliminary information statement on Schedule 14A with the SEC regarding Shareholder Approval by April 30, 2024 and file a definitive information statement on Schedule 14A with the SEC with respect to the Shareholder Approval as soon as permissible under applicable securities laws.

Management Comments

• The Company is pleased to offer to you the following modifications to the Transaction Documents with respect to the February 2024 Offering pursuant to this amendment letter.

Industry Context

This announcement reflects a common strategy for companies seeking capital through convertible notes, with adjustments to terms to attract investors and manage financial flexibility. The modifications to amortization and conversion options are typical features in such agreements.

Comparison to Industry Standards

• The offering size increase and modifications to amortization and conversion terms are within industry standards for convertible note agreements.
• Similar companies, such as those in the SaaS and healthcare technology sectors, often use convertible notes to raise capital.
• The requirement to file a preliminary information statement on Schedule 14A with the SEC regarding Shareholder Approval is a standard practice for companies seeking shareholder approval for certain transactions.

Stakeholder Impact

• Shareholders may be affected by the potential dilution from the conversion of notes.
• Holders of the notes benefit from the increased offering size and the voluntary conversion options.
• The company's employees and customers may benefit from the increased financial stability provided by the additional capital.

Next Steps

• File a preliminary information statement on Schedule 14A with the SEC regarding Shareholder Approval by April 30, 2024.
• File a definitive information statement on Schedule 14A with the SEC with respect to the Shareholder Approval as soon as permissible under applicable securities laws.
• Obtain Shareholder Approval within sixty (60) calendar days after the Allocated Exchange Cap Depletion Date.
• Secure the listing of additional Common Stock issued under the amended February 2024 Offering.
• File a Current Report on Form 8-K describing the terms of the transactions contemplated by the amendment by a specified deadline.

Key Dates

Keywords

offering, convertible notes, amendment, securities, shareholder approval, registration statement, amortization, conversion, icoreconnect, notes